Status:
TERMINATED
Parecoxib in Renal Colic
Lead Sponsor:
Pfizer
Conditions:
Colic
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
This is a phase III, multicenter, randomized, single blind study designed to evaluate the efficacy and tolerability of a single dose of parecoxib compared with diclofenac in the treatment of acute pai...
Detailed Description
This study was prematurely discontinued May 3, 2004 due to slow recruitment. The decision to terminate the trial was not based on any safety concerns.
Eligibility Criteria
Inclusion
- diagnosis of renal colic;
- baseline pain \> 50 mm on VAS;
Exclusion
- evidence of neoplasm or any other severe disease of any organ, including any psychiatric illness;
- active GI disease (e.g. Crohn's disease or ulcerative colitis) or any evidence of concomitant disease which may lead to early termination of the study
Key Trial Info
Start Date :
April 1 2002
Trial Type :
INTERVENTIONAL
End Date :
April 1 2004
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00139646
Start Date
April 1 2002
End Date
April 1 2004
Last Update
May 6 2008
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Alessandria, Italy, 15100
2
Pfizer Investigational Site
Grosseto, Italy, 58100
3
Pfizer Investigational Site
Modena, Italy, 41100
4
Pfizer Investigational Site
Pavia, Italy, 27100